To study the efficacy of Gum Arabic as an immuno modulator and anti-inflammatory agent among COVID 19 seropositive patients..Half of participants will receive Gum Arabic and the other half will receive placebo
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean change from baseline score of Immune Response to end of the trial ( Time Frame: up to 4 weeks )
Timeframe: 4 weeks
Mortality rate
Timeframe: from the date of assignment until the date of first documented progression or date of death from any cause, whichever comes first, assessed up to two months